For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
Before You Checkout
Bundle complementary compounds together — priced below buying each separately.
A synthetic analog of growth hormone-releasing factor (GRF 1-44) with a trans-3-hexenoic acid modification. Investigated in preclinical research for its selective stimulation of the growth hormone axis and downstream signaling pathways in in-vitro and animal model studies.
Dosage
5mg
Purity
99.3%
Form
Lyophilized Powder
Third-Party Tested
HPLC & mass-spec verified · every batch
Every batch is independently verified by HPLC and mass spectrometry to 99.3% purity and ships with a lot-specific Certificate of Analysis.
View all certificatesBOGO Sale — Buy More, Get More Free
Discount applied automatically in cart.
$44.95
Research Application Guidelines
This research compound is designed exclusively for controlled in vitro studies carried out by trained professionals. It is not intended for human or animal use and must not be incorporated into foods, cosmetics, medications, or diagnostic processes.
Regulatory Notice
This material has not been evaluated by the FDA and is not sold for the purpose of diagnosing, treating, curing, or preventing any condition. All handling, storage, and research use must comply with applicable regulations and institutional requirements.
Purchase & Responsibility Agreement
By purchasing from Ascension Labs, the buyer confirms that they are a qualified researcher or authorized laboratory. All sales are final. The buyer assumes full responsibility for the proper handling, storage, usage, and regulatory compliance of this material.
What's Included
Storage Guidelines
Quality Assurance
Disclaimer: Our peptides are research-grade products for laboratory use only. They are not approved for human consumption or medical use. Always follow proper laboratory safety protocols.
Tesamorelin is a stabilized analog of growth-hormone-releasing factor (GRF 1-44) with a trans-3-hexenoic acid modification. It is studied in vitro for selective growth-hormone-axis stimulation.
Also referred to as: Tesamorelin acetate, GRF 1-44 analog, TH9507.
Tesamorelin, also known as TH9507, is a stabilized analog of growth-hormone-releasing factor GRF(1-44). It carries a trans-3-hexenoic acid group attached to the N-terminus of the 44-amino-acid sequence. This modification defines its class as a long-acting GHRH analog, and it is characterized in research by this hexenoyl modification and full-length GRF backbone.
Tesamorelin is studied as a selective agonist at the GHRH receptor, stimulating the growth-hormone axis in preclinical models. Research also examines its influence on lipid-metabolism and visceral-adipose pathways in cultured and animal systems. Receptor activation and downstream signaling are characterized in vitro, keeping all observations within non-human, mechanism-focused laboratory contexts.
Unmodified GRF(1-44) is rapidly degraded, partly by DPP-4 enzymatic cleavage. Tesamorelin's N-terminal trans-3-hexenoic acid group confers resistance to this breakdown, extending its stability and activity in research conditions. Comparative studies use this difference to examine more durable GHRH-receptor stimulation than the native releasing factor supports in vitro.
Yes. Every batch of Tesamorelin is independently tested by HPLC and mass spectrometry, and ships with a lot-specific Certificate of Analysis verifying 99.3% purity and molecular identity.
Store lyophilized Tesamorelin at -20°C for long-term storage or 2-8°C short-term. After reconstitution, keep refrigerated at 2-8°C and avoid repeated freeze-thaw cycles.
No. Tesamorelin is sold strictly for in-vitro research and laboratory use only. It is not a drug or supplement and is not intended for human or animal consumption.